| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Medipal Holdings Corp
|
29.131m | 23.83% | — | Sep 30 2025 |
| 2 |
Future Brain KK
|
8.711m | 7.13% | — | Sep 30 2025 |
| 3 |
Nomura Trust & Banking (Trust)
|
6.298m | 5.15% | — | Sep 30 2025 |
| 4 |
Nomura Asset Management Co., Ltd.
|
5.528m | 4.52% | -1.562m | Feb 14 2025 |
| 5 |
Kissei Pharmaceutical Co Ltd
|
4.918m | 4.02% | — | Sep 30 2025 |
|
1
Medipal Holdings Corp
|
23.83%
29.131m
|
|
2
Future Brain KK
|
7.13%
8.711m
|
|
3
Nomura Trust & Banking (Trust)
|
5.15%
6.298m
|
|
4
Nomura Asset Management Co., Ltd.
|
4.52%
5.528m
|
|
5
Kissei Pharmaceutical Co Ltd
|
4.02%
4.918m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 44.65% of Jcr Pharmaceuticals Co.,ltd., with Medipal Holdings Corp the biggest at 23.83%, followed by Future Brain KK (7.13%) and Nomura Trust & Banking (Trust) (5.15%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


